section name header

Pronunciation

poe-TASS-ee-um KLOR-ide

Classifications

Therapeutic Classification: mineral and electrolyte replacements/supplements

Indications

REMS

Action

Therapeutic Effects:

Pharmacokinetics

Absorption: Well absorbed following oral administration. IV administration results in complete availability.

Distribution: Enters extracellular fluid; then actively transported into cells.

Metabolism/Excretion: Excreted by the kidneys.

Half-life: Unknown.

Time/Action Profile

(↑ in serum potassium concentrations)

ROUTEONSETPEAKDURATION
POunknown1–2 hrunknown
IVrapidend of infusionunknown

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: ARRHYTHMIAS, ECG changes.

F and E: hyperchloremia, hyperkalemia.

GI: abdominal pain, diarrhea, flatulence, nausea, vomiting.
tablets, capsules only: GI ulceration, stenotic lesions.

Local: irritation at IV site.

Neuro: confusion, paralysis, paresthesia, restlessness, weakness.

Interactions

Drug-Drug:

Route/Dosage

Expressed as mEq of potassium.

Normal Daily Requirements

Prevention of Hypokalemia During Diuretic Therapy

Treatment of Hypokalemia

Availability

Assessment

Lab Test Considerations: Toxicity and Overdose:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Klor-Con, Klor-Con M10, Klor-Con M15, Klor-Con M20, K-Tab, Slow-K

Canadian Brand Names

Micro-K

Code

NDC Code*